Functional improvement in chronic human spinal cord injury: Four years after acidic fibroblast growth factor
Abstract Few treatments have proven effective for patients with chronic spinal cord injury (SCI). This study aimed to evaluate the efficacy and safety of acidic fibroblast growth factor (aFGF) in human SCI. This was an open-label prospective clinical trial of aFGF with an extended follow-up to 48 mo...
Main Authors: | Chin-Chu Ko, Tsung-Hsi Tu, Jau-Ching Wu, Wen-Cheng Huang, Yun-An Tsai, Shih-Fong Huang, Hsueh-Chen Huang, Henrich Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2018-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-018-31083-4 |
Similar Items
-
Acidic Fibroblast Growth Factor in Spinal Cord Injury
by: Chin-Chu Ko, et al.
Published: (2019-12-01) -
Multifaceted Benefits of GDF11 Treatment in Spinal Cord Injury: In Vitro and In Vivo Studies
by: May-Jywan Tsai, et al.
Published: (2022-12-01) -
The Application of an Omentum Graft or Flap in Spinal Cord Injury
by: Li-Yu Fay, et al.
Published: (2021-07-01) -
Characterizing the Neuroprotective Effects of S/B Remedy (<i>Scutellaria baicalensis</i> Georgi and <i>Bupleurum scorzonerifolfium</i> Willd) in Spinal Cord Injury
by: Tsung-Hsi Tu, et al.
Published: (2019-05-01) -
Local inhibition of matrix metalloproteinases reduced M2 macrophage activity and impeded recovery in spinal cord transected rats after treatment with fibroblast growth factor-1 and nerve grafts
by: Chuan-Wen Chiu, et al.
Published: (2018-01-01)